此次收购的债权包含两部分：一是债务人公司保山鑫盛泰纸业(主营纸品制造、再生料回收等，正处于 破产重整阶段)的未偿本金 2566 万元人民币及应计利息 / 罚款，对应抵押资产为约 9.7 万平方米地块及 2.1 万平方米厂房等;二是昭通市峻驰商贸(主营建筑材料等销售)的未偿本金 1000 万元人民币及应计利息 / 罚款(无抵押)。截至 2025 年 10 月 20 日，两项债权未偿总金额合计约 7479.16万元人民币。 董事会认为，鉴于该公告所述债务人公司正进行破产重整，收购其有抵押债务属战略性举措，原因为集 团作为债务人公司破产重整的投资者，将无论如何须根据重整计划向卖方支付与债权转让合同代价金额 相若的款项。参与公开竞价及预付款项为公司提供机会，可提前且更有效地控制债务人公司为担保其结 欠卖方的债务而以卖方为受益人抵押的资产( 即若干土地及附属建筑物 )。此外，卖方为债务人公司的 五名有抵押债权人之一，于即将召开的债权人会议上持有关键表决权，以批准重整计划，塬因为其已确 认债务申索价值约为人民币3832万元，占破产重整 程序中有抵押债务总额约26.1 %。透过订立债权转 让合同 ，该集团将向卖方收购其对债 ...

12月17日，宁夏中科生物科技股份有限公司(以下简称"*ST宁科（600165）")再度开盘"一字"涨停，从 12月11日第一个涨停计算，已实现涨停五连板。 本报记者陈潇 消息面上，12月16日，公司公告称，公司于2025年12月15日收到中国证券登记结算有限责任公司出具的 《证券过户登记确认书》，获悉管理人已将8.82亿股转增股票(占公司总股本的54.64%)由管理人证券账 户(即宁夏中科生物科技股份有限公司破产企业财产处置专用账户)过户至重整投资人指定主体证券账 户。 不过，吴婉莹亦表示，此阶段仍存在显著风险，例如执行过程复杂可能导致计划未能按期完成，经营改 善不及预期，市场或行业环境突变等。若最终执行失败，公司仍将面临破产清算并终止上市的风险。 公开资料显示，*ST宁科旗下核心子公司宁夏中科生物新材料有限公司(以下简称：中科新材)于2024年2 月7日进入停产状态后，根据相关规定，公司股票自2024年4月8日起已被实施其他风险警示。虽然中科 新材近期已经实现复工复产，但能否实现可持续的正常生产经营能力，仍有不确定性。 此外，因公司2021年至2023年连续三个会计年度经审计扣除非经常性损益前后净利润孰低 ...

材料工业是国民经济的基础产业，新材料是材料工业发展的先导，国家先后将新材料列入国家高新技术 产业和重点战略性新兴产业。而位于鲁中的淄博齐翔腾达（002408）化工股份有限公司（以下称"齐翔 腾达"）手握碳四深加工能力和全球最大的产能，被誉为国内高端化工新材料的领军企业。 面对外省国资重大利益关切，由省委政法委牵头，省市法院、省国资委、淄博政法委等单位密切参与， 坚持市场化、法治化原则不动摇，与各方对接沟通200余次，达成"定分止争、维护国有资产安全、扶持 优质企业破茧重生、维护两地社会稳定"的合作共识，共同推进齐翔集团破产重整方案的优化执行，确 保了程序推进依法依规、商谈博弈多赢共赢。 面对分散多地的债权人和短期内无法确定的债权，工作团队创新"求同债权先行确认、存疑债权存留后 付"的动态清偿方式，既高效推进债权清偿，又有效回应债权人异议。对已经确认的债权，先行进行清 偿，以保证相关债权人利益，同时进行精准评估、预测，保留足够的金额，用于二次清偿。破产重整7 个月后，存疑债权完成确定的第一时间，二次清偿顺利进行，普通债权人全部按比例拿到了清偿款。 2023年5月31日，淄博中院作出裁定，确认齐翔集团重整计划执行 ...

Core Viewpoint - The article discusses the financial struggles and potential restructuring of Singshan Group, highlighting the interest from significant investors and the challenges faced in the restructuring process [4][6][28]. Group 1: Capital Involvement - Singshan Group's restructuring has attracted notable investors, including Fangda Carbon and Hunan Salt Industry Group, both of which have relevant industrial backgrounds and financial capabilities [6][11][14]. - The second round of investor recruitment for Singshan Group has seen increased interest compared to the first round, indicating the group's perceived value despite its financial difficulties [10][15]. Group 2: Financial Status and Assets - Singshan Group has reported over 40 billion yuan in debts, yet it possesses significant assets, including a 23.37% stake in Singshan Co., valued at approximately 7 billion yuan based on the company's market capitalization [18][19]. - Singshan Co. has shown a recovery in its financial performance, with a revenue of 14.81 billion yuan in the first three quarters of the year, marking an 11.48% increase year-on-year, and a net profit of 284 million yuan, up 1121.72% [22][23]. Group 3: Restructuring Challenges - The restructuring process is under tight deadlines, with a critical date of December 20 for the submission of a viable restructuring plan, raising concerns about the feasibility of a successful outcome [29][30]. - Previous restructuring proposals faced criticism for lacking clarity on improving operational conditions and debt resolution, which may hinder future proposals from gaining approval [30][31]. Group 4: Competitive Landscape - Among the competing investors, Fangda Carbon has substantial backing but faces challenges due to its own high debt levels, while Hunan Salt Industry Group, with its state-owned background, may have an advantage in gaining creditor trust [32][33].

Core Viewpoint - Suning, a well-known brand group, has been declared insolvent, facing a massive debt of 230 billion yuan and asset liquidation valued at approximately 41 billion yuan, leading to a potential adjustment or complete loss of shareholder equity [3][8]. Group 1: Company Overview - In 2019, Suning's revenue was approximately 269.23 billion yuan, with a GMV of 378.74 billion yuan, and it operated over 8,216 offline stores across China and internationally [12]. - Suning's brand value was estimated at 39 billion USD, making it one of the most valuable brands in China's retail sector [12]. - The company expanded from a single appliance retailer to a diversified "omni-channel retail ecosystem," including e-commerce, logistics, financial services, and more [16]. Group 2: Mistakes Made by Suning - Suning made significant strategic investments in real estate during 2017-2018, locking substantial funds in long-term projects, which strained liquidity [26]. - In 2019, Suning acquired a majority stake in Carrefour China, which subsequently faced continuous losses and goodwill impairment [29]. - The company struggled with high operational costs due to its large offline store network, which conflicted with its O2O strategy [31]. - Over the past decade, Suning's extensive investments in various sectors diluted its resources, leading to increased debt and liquidity issues [33]. - The COVID-19 pandemic exacerbated existing problems, revealing vulnerabilities in Suning's business model and asset management [34]. Group 3: Leadership Accountability - Zhang Jindong, the founder of Suning, and his son Zhang Kangyang have faced scrutiny for their management decisions, including the acquisition of Inter Milan, which ultimately did not yield the expected benefits [36][45]. - The financial strain from the Inter Milan investment, including a €275 million loan that could not be repaid, led to a loss of control over the club [45]. - Critics argue that while Zhang Kangyang has international experience, he lacks the expertise to manage large-scale businesses effectively, particularly in the competitive retail and sports sectors [46]. Group 4: Restructuring Efforts - Suning's restructuring plan aims to manage debt through a trust, selling valuable assets while continuing operations for viable companies [50]. - The restructuring proposal has faced multiple delays, indicating ongoing negotiations among creditors and potential legal uncertainties [50]. - If the restructuring plan is approved, it may allow for the continuation of core retail operations, but the path to recovery and debt repayment remains challenging [54].

Core Viewpoint - Renfu Pharmaceutical (600079.SH) is facing a fine of 17.5 million yuan due to violations associated with its former controlling shareholder, Dongdai Group, marking the end of its historical burdens and paving the way for a "third entrepreneurship" under the control of China Merchants Group [2] Group 1: Company Developments - Renfu Pharmaceutical's stock will be suspended for one day on December 15, 2025, and will be subject to risk warnings starting December 16, 2025, with its A-share name changing to "ST Renfu" [2] - The company reported a revenue of 17.883 billion yuan and a net profit attributable to shareholders of 1.1 billion yuan, marking a year-on-year increase of 6.22%, ending a two-year decline [7] - The company has successfully rectified the violations mentioned in the administrative penalty notice, ensuring that future operations will not be affected [7] Group 2: Industry Context - Dongdai Group, once the largest private enterprise group in Hubei, controlled four A-share listed companies and had total assets exceeding 100 billion yuan before facing a debt crisis [4] - The debt crisis led to the transfer of control of its listed companies to state-owned enterprises, with significant changes in management and operational performance observed post-acquisition [5][6] - Other companies under Dongdai Group, such as Santai Cableway and ST Mingcheng, have shown remarkable recovery in performance after the change in control, with Santai Cableway achieving a revenue increase of 180.67% in 2023 [3][8]

Core Viewpoint - Renfu Pharmaceutical (600079.SH) is facing an administrative penalty of 17.5 million yuan due to violations associated with its former controlling shareholder, Dongdai Group, marking the end of its historical burdens and paving the way for a "third entrepreneurship" under the control of China Merchants Group [1] Group 1: Company Developments - Renfu Pharmaceutical's stock will be suspended for one day on December 15, 2025, and will be subject to risk warnings starting December 16, 2025, with its A-share abbreviation changing to "ST Renfu" [1] - The company reported a revenue of 17.883 billion yuan for the first three quarters of this year, with a year-on-year net profit increase of 6.22%, ending a two-year decline [6] - The asset-liability ratio of Renfu Pharmaceutical has decreased to 40.53%, and multiple new drugs are entering clinical trials, accelerating its transition from imitation to innovation with the support of state-owned enterprises [6] Group 2: Industry Context - Dongdai Group, once the largest private enterprise group in Hubei Province, controlled four A-share listed companies, including Renfu Pharmaceutical, with total assets exceeding 100 billion yuan [3] - Following a debt crisis, Dongdai Group has transferred control of its listed companies to state-owned enterprises, with Renfu Pharmaceutical being acquired by China Merchants Group for 11.8 billion yuan, setting a record for state-owned acquisitions in the pharmaceutical industry [4] - Other companies in the Dongdai Group, such as Santai Cableway and ST Mingcheng, have also undergone significant transformations post-acquisition, with Santai Cableway returning to profitability and ST Mingcheng experiencing a substantial increase in revenue [2][4]

备受关注的杉杉集团破产重组案又现新剧情，中国宝安（000009）拟入局。 12月12日晚，中国宝安公告称，董事会审议通过了《关于参与杉杉集团及其全资子公司实质合并重整投资人招募的议案》，同意公司作为重整投资联合体 (下称"联合体")牵头人，联合下属子公司贝特瑞新材料集团股份有限公司(以下简称"贝特瑞")及其他潜在投资人参与杉杉集团及其全资子公司宁波朋泽贸 易有限公司(下称"宁波朋泽")的实质合并重整投资人招募。 目前，中国宝安按照杉杉集团管理人发布的公告要求，已提交了报名材料，缴纳了尽职调查保证金5000万元，并委托了中介机构开展尽职调查。公司董事 局授权公司管理层拟定和提交重整投资方案，参与现场述标以及可能的竞争性谈判的工作。 中国宝安称，公司参与杉杉集团及其全资子公司宁波朋泽的实质合并重整投资人招募，联合体是否被确定为最终的重整投资人存在不确定性。 杉杉集团由知名浙商郑永刚创立，旗下杉杉股份（600884），是全球锂电池负极材料与偏光片行业龙头，但郑永刚不幸病故。杉杉集团的破产重整备受资 本市场关注，最终谁会成为重整参与方，不妨拭目以待。 因债务问题，2025年2月，浙江省宁波市鄞州区人民法院作出《民事裁 ...

Core Viewpoint - SAIC Hongyan's restructuring plan has been approved by the Chongqing Fifth Intermediate People's Court, marking a significant step towards its operational recovery and debt resolution [1][3]. Group 1: Restructuring Process - On July 1, 2025, Chongqing Anji Hongyan Logistics filed for bankruptcy restructuring for SAIC Hongyan due to its inability to repay debts and severe insolvency, despite having restructuring value [1]. - The court appointed Taihe Tai (Chongqing) Law Firm and Xinyong Zhonghe Accounting Firm as the managers for the restructuring process [1]. - A public recruitment for restructuring investors was initiated to facilitate the restructuring efforts [1]. Group 2: Investment and Financial Implications - On September 29, 2025, the board of Dongli Xinke approved a joint investment of 6.66 billion yuan to participate in SAIC Hongyan's restructuring, aiming for a 14.66% stake post-restructuring [2]. - The total investment from the consortium is expected to reach 30 billion yuan, targeting a 66% stake in SAIC Hongyan after restructuring [2]. - The restructuring plan was approved by creditors on December 10, 2025, indicating a consensus on the proposed recovery strategy [2]. Group 3: Operational Strategy and Market Position - The court found that the restructuring plan aligns with the principles of fair repayment and maximization of creditor interests, with a higher debt repayment rate compared to liquidation [3]. - The operational strategy includes leveraging SAIC Hongyan's complete heavy truck production line and advanced technology, focusing on both domestic and international markets while enhancing the "Hongyan" brand [3]. - SAIC Hongyan's strong market presence in the dump truck sector and opportunities in the export and new energy markets are highlighted as key advantages for future growth [4]. Group 4: Impact on Dongli Xinke - Following the restructuring approval, Dongli Xinke will adjust its financial statements to exclude SAIC Hongyan, which is expected to positively impact its financial metrics for 2025 [4]. - The one-time gain from this adjustment is projected to represent approximately 150% to 180% of Dongli Xinke's net profit attributable to the parent company for 2024 [4].

12月12日，法国法院12月11日作出宣判，资不抵债的法国最大家电制造商白朗集团(Brandt)进入司法清 算程序。作为唯一备选的救济措施，由政府支持的合作制公司重组方案遭法院否决，这意味着该集团将 终止经营活动，本土700多名员工面临失业。法媒评论说，法国工业再遭沉重一击。 白朗集团由法国企业家埃德加·白朗(Edgar Brandt)于1924年成立，一度成为法国工业的标志之一。在发 展历程中曾多次易手，直至2014年由阿尔及利亚最大私企Cevital集团收购。近年来，受市场竞争激烈、 房地产业低迷等因素影响，公司陷入严重财务危机，自今年10月1日起进入破产重整程序。 美股频道更多独家策划、专家专栏，免费查阅>> 责任编辑：栎树 ...